May 7, 2026 · Blood · DOI: 10.1182/blood.2025029923

How I utilize somatic alterations in the diagnosis, risk stratification, and therapy of hypocellular bone marrow failure

Listen to this summary

The authors investigate how somatic alterations, such as clonal hematopoiesis, can enhance the diagnosis and risk stratification of hypocellular bone marrow failure (BMF), particularly in distinguishing between immune aplastic anemia, myelodysplastic syndromes, and inherited bone marrow failure syndromes. They aim to establish the clinical significance of these alterations in guiding treatment decisions and estimating the risk of secondary myeloid neoplasms in patients with BMF.

Emma M Groarke, Fernanda Gutierrez-Rodrigues, Bhavisha A Patel

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play